NDC 59137-510-00 - Rasuvo
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59137-510
- Requested NDC
- 59137-510-00
- Package NDCs from labels
- 59137-510-00, 59137-510-01, 59137-510-04
- Manufacturer
- Medexus Pharma Inc.
- Effective date
- 2025-12-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rasuvo - Medexus Pharma Inc. | Medexus Pharma Inc. | 2025-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59137-510-00 | Rasuvo | 0.2 mL in 1 PACKAGE | INJECTION, SOLUTION | 0.2 | 10 | |
| 59137-510-01 | Rasuvo | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 10 | |
| 59137-510-04 | Rasuvo | 4 in 1 CARTON | INJECTION, SOLUTION | 4 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59137-510-00 | ML - Milliliter | 59137-510 | 86878f7f-9b71-4176-94ad-678612ce2c7a | 1 | 2017-03-06 |
| 59137-510-01 | ML - Milliliter | 59137-510 | e0539e6e-8bcc-4c7d-b585-d84b04b7a790 | 1 | 2014-09-03 |
| 59137-510-04 | ML - Milliliter | 59137-510 | 6cb13e5e-f72f-4f6b-8ea5-44424903ce4d | 1 | 2014-09-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| methotrexate sodium | ACTIVE INGREDIENT | 3IG1E710ZN | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 | |
| methotrexate | ACTIVE MOIETY | YL5FZ2Y5U1 | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | RASUVO (METHOTREXATE) INJECTION, SOLUTION [MEDAC PHARMA, INC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | 059QF0KO0R |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | 059QF0KO0R |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride Hypertonicity Ophthalmic | SODIUM CHLORIDE | Rugby Laboratories | 7546770d-bc12-44b8-9fe0-fc3f5e1d12d1 | 2026-09-24 | Warnings | 451W47IQ8X |
| Rugby Eye Wash | WATER, PURIFIED | Rugby Laboratories | 1fee974b-4c29-4965-bd3d-da5e219eb13a | 2026-09-24 | Warnings | 059QF0KO0R |
| Sodium Chlorode Hypertonicity Ophthalmic Solution | SODIUM CHLORIDE | Rugby Laboratories | 822d25c0-71b3-421d-b702-4cded0c4ca32 | 2026-09-23 | Warnings | 451W47IQ8X |
| BURBLE | SODIUM CHLORIDE | LETS BURBLE, INC. | 17f48d4f-907c-3829-e063-6394a90ab202 | 2026-09-22 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | B. Braun Medical Inc. | f4284eb6-e553-46d4-90d8-efc80a90a480 | 2026-09-18 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.